Skip to main content

Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

View Cover

Overview

Contributors

Description

On September 1, 2020, the National Academies of Sciences, Engineering, and Medicine invited public comment on the Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, commissioned by the Centers for Disease Control and the National Institutes of Health. Input from the public, especially communities disproportionately affected by the COVID-19 pandemic, is essential to produce a final report that is objective, balanced, and inclusive. The public comment period was open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4.

In addition, the study committee hosted a listening session on Wednesday, September 2, from 12:00 to 5:00 p.m. ET to hear comments from the public. For more information, please visit the study webpage. If you have any questions, please email COVIDVaccineFramework@nas.edu.

Topics

Suggested Citation

National Academies of Sciences, Engineering, and Medicine. 2020. Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25914.

Import this citation to:

Publication Info

114 pages | 8.5 x 11
DOI: https://doi.org/10.17226/25914
Contents
Resources
Rights

Copyright Information

The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:

  • Republish or display in another publication, presentation, or other media
  • Use in print or electronic course materials and dissertations
  • Share electronically via secure intranet or extranet
  • And more

For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.

Click here to obtain permission for Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.

Translation and Other Rights

For information on how to request permission to translate our work and for any other rights related query please click here.

Copyright.com Customer Service

For questions about using the Copyright.com service, please contact:

Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Stats

Loading stats for Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine...